Ergoteles’s Ultralife ULBI Stock Holding History

Ergoteles’s Portfolio ULBI Stock Details ULBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-12,405	Closed	-$88K	–	1611
2021 Q3	$88K	Sell	12,405 -25,383	-67%	-$204K	﹤0.01%	1113
2021 Q2	$317K	Buy	+37,788	New	+$325K	0.01%	1043

Other funds holding ULBI

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

VWA

Visionary Wealth Advisors O'fallon, Illinois $2.26B AUM 19.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return

MPAM

Monarch Partners Asset Management Boston, Massachusetts $339M AUM 2.52% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Teton Advisors Rye, New York $142M AUM 42.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Ergoteles's ULBI Position: Q4 2021 in Review

Ergoteles sold out of Ultralife (ULBI) in Q4 2021, closing a stake of 12,405 shares — an estimated $88K sold.

Ergoteles first reported a position in ULBI in Q2 2021 and held it in 2 quarters. The position peaked at $317K in Q2 2021. 32 funds tracked by Wall St. Rank hold ULBI as of Q4 2021.

Ergoteles reported no remaining Ultralife position as of Q4 2021 after selling out during the quarter.
Ergoteles sold 12,405 Ultralife shares in Q4 2021, an estimated $88K.
Ergoteles first reported a position in Ultralife in Q2 2021 and held it in 2 quarters.
Ergoteles's Ultralife position peaked at $317K in Q2 2021.
32 funds tracked by Wall St. Rank held Ultralife as of Q4 2021.

Based on Ergoteles's 13F filing for Q4 2021, filed 14 Feb 2022.